What is the Return on Assets (ROA) of Singapore Medical Group this year?
The Return on Assets (ROA) of Singapore Medical Group is 0.08 undefined this year.
In 2024, Singapore Medical Group's return on assets (ROA) was 0.08, a 0% increase from the 0 ROA in the previous year.
Singapore Medical Group's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Comparing Singapore Medical Group's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Investors consider Singapore Medical Group's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Variations in Singapore Medical Group’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
The Return on Assets (ROA) of Singapore Medical Group is 0.08 undefined this year.
The ROA of Singapore Medical Group has increased by 0% compared to the previous year.
A high ROA is advantageous for investors of Singapore Medical Group, as it indicates that the company efficiently utilizes its assets and generates good profits.
A low ROA can be unfavorable for investors of Singapore Medical Group as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
An increase in ROA of Singapore Medical Group can be an indicator of improved efficiency in asset utilization and higher profitability.
A reduction in the ROA of Singapore Medical Group can be an indicator of lower asset efficiency and profitability.
Some factors that can influence the ROA of Singapore Medical Group include revenue, operating costs, asset structure, and industry average.
The ROA of Singapore Medical Group is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
To improve ROA, Singapore Medical Group can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
Over the past 12 months, Singapore Medical Group paid a dividend of 0 SGD . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Singapore Medical Group is expected to pay a dividend of 0.01 SGD.
The current dividend yield of Singapore Medical Group is 1.01 %.
Singapore Medical Group pays a quarterly dividend. This is distributed in the months of May, July, June, June.
Singapore Medical Group paid dividends every year for the past 6 years.
For the upcoming 12 months, dividends amounting to 0.01 SGD are expected. This corresponds to a dividend yield of 3.12 %.
Singapore Medical Group is assigned to the 'Health' sector.
To receive the latest dividend of Singapore Medical Group from 5/13/2022 amounting to 0.009 SGD, you needed to have the stock in your portfolio before the ex-date on 5/4/2022.
The last dividend was paid out on 5/13/2022.
In the year 2023, Singapore Medical Group distributed 0.009 SGD as dividends.
The dividends of Singapore Medical Group are distributed in SGD.
Our stock analysis for Singapore Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Singapore Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.